• Neuron Specific Enolase (NSE), CSF
  • Angiosarcoma, MYC (8q24) Amplification, FISH, Tissue
  • Chromosome Analysis, Lymphoid Tissue
  • Butalbital, Serum
  • Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
  • Zika Virus, Molecular
  • Pseudocholinesterase, Dibucaine Inhibition
  • Aspergillus (Galactomannan) Antigen, Bronchoalveolar Lavage
  • Prenatal Aneuploidy Detection, FISH
  • Type and Screen
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MYOZ2 (Calsarcin-1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MYOZ2 (Calsarcin-1) Gene Mutation Analysis
Medical Test

Turnaround Time
Access to MYOZ2 (Calsarcin-1) Gene Mutation Analysis is restricted.
Loading...